| CAS NO. |
84371-65-3 |
| Type |
Pharmaceutical Intermediates |
| Sample |
Availiable |
| MF |
C29H35NO2 |
| Grade Standard |
Medicine Grade |
| Color |
Yellow |
| Storage |
Cool Dry Place |
| Transport Package |
1kg/bag, 25kg/Drum |
| Trademark |
Crovell |
Mifepristone is a kind of antagonist of the progestational and glucocorticoid hormone. It is mainly used for the treatment of hypercortisolism in patients with nonpituitary cushing syndrome. During the treatment of Cushing's syndrome, mifepristone takes effect through interfering with the binding of cortisol to its receptor. It reduces the effects of excess cortisol (e.g., high blood sugar levels) without causing decreased cortisol production. It can also be used to end a pregnancy. Its inhibition on progesterone can induce bleeding during the luteal phase and in early pregnancy.
Mifepristone is an orally-active progesterone and glucocorticoid receptor antagonist indicated for use as a post-coital contraceptive. In addition to being an abortifacient, mifepristone is reported to be effective in the treatment of ocular hypertension; its potential therapeutic effect in hormone-dependent tumors is currently under investigation.
Mifepristone plays a role on the receptor level of new antifertility dru gs, no progesterone, androgen, estrogen activity. It has an effect on softening and dilating uterine neck. It is a new anti - progesterone, and anti-glucocorticoid activity, without progesterone, estrogen, androgen and estrogen activity. And progesterone receptor affinity is 5 times stronger than progesterone. For termination of early pregnancy, reinstating menstruation and terminating pregnancy, fetal death, etc. In induction of labor.
Audited Supplier 
){kind=link}
){kind=link}